Objective: Clinical and genetic predictors of response to antiepileptic drugs (AEDs) are largely unknown. We examined predictors of lacosamide response in a real-world clinical setting.
Methods: We tested the association of clinical predictors with treatment response using regression modeling in a cohort of people with refractory epilepsy.
Objective: There is little detailed phenotypic characterization of bilateral hippocampal sclerosis (HS). We therefore conducted a multicenter review of people with pharmacoresistant epilepsy and bilateral HS to better determine their clinical characteristics.
Methods: Databases from 11 EPIGEN centers were searched.